RhythmAnalytics vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by Mycardium AI Limited

AI Verdict

RhythmAnalytics specializes in AI-powered interpretation of single-lead ECG data for detecting cardiac arrhythmias, offering clinical decision support for rhythm disorders. In contrast, 1CMR Pro is an AI-enhanced software for Cardiac MRI reporting, designed to improve the speed and precision of volumetric and functional measurements from MRI scans. While both are AI tools for cardiology, they address fundamentally different diagnostic modalities and clinical problems, making them adjacent rather than direct competitors.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from single-lead ECG data for enhanced clinical decision support. This cloud-based solution is ideal for integrating with existing FDA-cleared ECG devices to provide beat-by-beat analysis and detect a wide range of rhythm abnormalities efficiently.

View RhythmAnalytics →

Choose 1CMR Pro if…

Choose 1CMR Pro if your focus is on revolutionizing Cardiac MRI reporting with AI-enhanced precision and speed for volumetric and functional measurements. This on-premise software is best suited for institutions requiring highly accurate and consistent cardiac MRI analysis, ensuring local data processing and clinician control over transparent contours for critical diagnostic insights.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics 1CMR Pro
Pricing Contact vendor Contact for pricing
Deployment Cloud-based API On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

1CMR Pro

Tool B, 1CMR Pro, offers transparent and editable contours for clinician control and features 'human-in-the-loop AI,' which directly enhances user trust and allows for fine-tuning of AI outputs in a diagnostic setting. While Tool A, RhythmAnalytics, provides a cloud-based API for integration, Tool B's focus on direct clinical interaction and control over complex MRI analysis gives it an edge in practical clinical usability.

Clinical Value

1CMR Pro

Tool B, 1CMR Pro, demonstrates superior clinical value by achieving up to 40% higher precision than manual analysis and showing superior precision to both human experts and prior FDA-cleared software for critical measurements like LVEF and LV mass. Tool A, RhythmAnalytics, also shows strong performance, outperforming cardiologists in arrhythmia detection with high sensitivity and specificity. However, Tool B's quantifiable superiority in precision for complex cardiac MRI analysis, a key factor for diagnosis and disease tracking, gives it a slight advantage.

Pricing & Value

Tie

Both tools have opaque pricing models, with neither publicly disclosing their costs and both requiring direct contact with the vendor for pricing information. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their value for money.

Enterprise Readiness

1CMR Pro

Tool B, 1CMR Pro, demonstrates stronger enterprise readiness through its ISO 27001 certification and on-premise deployment with local data processing, which is highly beneficial for institutions with strict data governance and security requirements. While Tool A, RhythmAnalytics, is explicitly HIPAA compliant and FDA cleared, Tool B's additional certifications and data handling approach provide a more robust offering for enterprise environments.

Innovation

1CMR Pro

Tool B, 1CMR Pro, showcases greater innovation by achieving 'superhuman' precision in complex cardiac MRI analysis and incorporating 'transparent and editable contours' for clinician control, fostering trust and adaptability in AI outputs. Tool A, RhythmAnalytics, is innovative in automating ECG interpretation and outperforming cardiologists, but Tool B's advanced approach to a more specialized imaging modality, combined with user-centric control features, represents a more significant leap in AI application.

Support & Docs

Tie

There is no specific information available in the provided structured facts or web search results regarding the quality or availability of support and documentation for either RhythmAnalytics or 1CMR Pro. Therefore, a meaningful comparison on this dimension cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics 1CMR Pro
Product Name RhythmAnalytics 1CMR Pro
Company Biofourmis Singapore Pte. Mycardium AI Limited
Primary Function AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support. AI-enhanced Cardiac MRI reporting software that delivers up to 40% more precise measurements, enabling faster and more consistent cardiac MRI analysis.
Target Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology
Key Feature: Modality/Analysis Type Automated interpretation of cardiac arrhythmias from single-lead ECG data AI-enhanced Cardiac MRI Reporting with automated volumetric and functional measurements
Key Feature: Specific Capability Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) Achieves up to 40% higher precision than manual analysis; transparent and editable contours for clinician control

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and 1CMR Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics by Biofourmis provides automated interpretation of single-lead ECG data for cardiac arrhythmias, offering clinical decision support for monitoring and rapid diagnosis. 1CMR Pro by Mycardium AI enhances Cardiac MRI reporting by automating volumetric and functional measurements, aiming to improve the speed, accuracy, and consistency of diagnostic imaging analysis.
RhythmAnalytics has demonstrated cardiologist-level arrhythmia detection and classification with a sensitivity of 90.8% and specificity of 98.2%, outperforming a panel of cardiologists and other deep learning systems. 1CMR Pro achieves up to 40% higher precision than manual analysis, with its convolutional neural networks trained on extensive datasets including 700,000 cine images and 60,000 expert segmentations, and validated across multi-centre datasets.
RhythmAnalytics is designed for Cardiology, Emergency Medicine, and Internal Medicine, focusing on the detection of over 15 types of cardiac arrhythmias from single-lead ECG data. 1CMR Pro is tailored for Cardiology and Radiology, specializing in AI-enhanced Cardiac MRI reporting, including automated volumetric and functional measurements.
While specific learning curve details for RhythmAnalytics are not provided, it offers automated interpretations as clinical decision support, implying physician review and validation. 1CMR Pro explicitly features 'transparent and editable contours for clinician control,' suggesting physicians can review and adjust automated measurements to ensure accuracy and maintain oversight.
While not explicitly detailed for RhythmAnalytics, clinical decision support tools typically include audit trails to track interpretations and user interactions for quality assurance. 1CMR Pro's 'transparent and editable contours' suggest a system where clinician modifications can be tracked, contributing to an audit trail for regulatory and quality assurance purposes.
AI Tool Finder
AI-powered search. Results may not be comprehensive.